Serum dehydroepiandrosterone sulphate levels and laboratory and clinical parameters indicating expression of disease are not associated with fatigue, well-being and functioning in patients with primary Sjögren’s syndrome.

Translated title of the contribution: Serum dehydroepiandrosterone sulphate levels and laboratory and clinical parameters indicating expression of disease are not associated with fatigue, well-being and functioning in patients with primary Sjögren’s syndrome.

A. Hartkamp, R. Geenen, A.A. Kruize, E.R. Bossema, G.L.R. Godaert, H. Bootsma, J.W.J. Bijlsma, R.H.W.M. Derksen

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionSerum dehydroepiandrosterone sulphate levels and laboratory and clinical parameters indicating expression of disease are not associated with fatigue, well-being and functioning in patients with primary Sjögren’s syndrome.
Original languageUndefined/Unknown
Pages (from-to)318-321
Number of pages4
JournalClinical and Experimental Rheumatology
Volume29
Issue number2
Publication statusPublished - 2011

Cite this